Assessment of the relationship between methylenetetrahydrofolate reductase polymorphism and acute lymphoblastic leukemia: Evidence from an updated meta-analysis
The decision should be individualized based on your specific health status, treatment goals, and the reason for discontinuation
Patients experiencing adverse effects should report them to their healthcare provider and consider reporting to the FDA MedWatch program (www.fda.gov/medwatch or 1-800-FDA-1088)
"If they're not providing you that offer of patient counseling or you're calling into that pharmacy and they don't allow you to, you know, be progressed to a pharmacist where you can ask questions, that would be something that I would call a red flag." She says prices that are too low and pharmacies that don't ask for a prescription should also trigger alarm bells
Many overlook the role C-rating plays in reducing this effect
If side effects are bad or you dont feel that the drug is effective, you may need a change in your dosage or the type of medication